Analysis
Berry Street, a US startup that connects patients with registered dietitians and bills insurance for the visits, is merging with Healthify, the Indian consumer health and nutrition platform, TechCrunch reported, citing rising GLP-1 adoption as the driver.
Berry Street's business rests on an underused piece of the US benefits system: medical nutrition therapy is a covered benefit under most commercial plans, often with no copay, and almost nobody uses it because finding an in-network dietitian is difficult. Berry Street built the matching and billing infrastructure and grew quickly on that arbitrage. Healthify, founded in 2012 as HealthifyMe by Tushar Vashisht and Sachin Shenoy, took the opposite route -- a consumer subscription app with tens of millions of users in India and a large coaching workforce.
“Berry Street built the matching and billing infrastructure and grew quickly on that arbitrage.”
GLP-1 drugs are the connective logic. Patients on semaglutide and tirzepatide eat substantially less, which raises real risks of muscle loss and nutrient deficiency, and clinical guidance increasingly pairs the prescription with structured nutrition support. That turns dietitian access from a wellness nicety into part of a drug protocol, with a payer willing to fund it.
The hard part is the merger itself. Combining a US regulated-billing business with an Indian consumer subscription business means two revenue models, two compliance regimes and two very different cost structures for delivering human coaching. Cross-border health mergers have a poor track record precisely because clinical labor does not port across regulatory borders, and the value here depends on whether Healthify's coaching capacity can legally serve US patients or merely support them.